Cargando…

Liquid Biopsy in the Oncological Management of a Histologically Undiagnosed Lung Carcinoma: A Case Report

Lung cancer is one of the most common and lethal cancers worldwide. Numerous medications targeting specific molecular alterations in non-small cell lung cancer have been introduced in the last decade and have revolutionized the clinical management of the disease. Their use has brought to a parallel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fadda, Giovanni M., Lobrano, Renato, Casula, Milena, Pisano, Marina, Pazzola, Antonio, Cossu, Antonio, Palmieri, Giuseppe, Paliogiannis, Panagiotis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694216/ https://www.ncbi.nlm.nih.gov/pubmed/36579578 http://dx.doi.org/10.3390/jpm12111874

Ejemplares similares

Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma
por: Casula, Milena, et al.
Publicado: (2023)

PD-L1 Expression in Cutaneous Angiosarcomas: A Systematic Review with Meta-Analysis
por: Lobrano, Renato, et al.
Publicado: (2023)

Mammary-like adenocarcinoma of the vulva: a rare case report with next generation sequencing
por: Lobrano, Renato, et al.
Publicado: (2023)

KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors
por: Palomba, Grazia, et al.
Publicado: (2020)

Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy?
por: Palmieri, Giuseppe, et al.
Publicado: (2021)

EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma
por: Colombino, Maria, et al.
Publicado: (2019)

Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study
por: Paliogiannis, Panagiotis, et al.
Publicado: (2022)

Primary Melanoma of the Lung: A Systematic Review
por: Paliogiannis, Panagiotis, et al.
Publicado: (2020)

Perivascular Epithelioid Cell Tumors (PEComas) of the Orbit
por: Paliogiannis, Panagiotis, et al.
Publicado: (2017)

Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic Targets
por: Palmieri, Giuseppe, et al.
Publicado: (2015)

Impact of tissue type and content of neoplastic cells of samples on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma
por: PALIOGIANNIS, PANAGIOTIS, et al.
Publicado: (2015)

Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach
por: Manca, Antonella, et al.
Publicado: (2019)

Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)
por: Vanni, Irene, et al.
Publicado: (2020)

KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma
por: PALIOGIANNIS, PANAGIOTIS, et al.
Publicado: (2014)

Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients
por: Colombino, Maria, et al.
Publicado: (2020)

Genetic alterations in main candidate genes during melanoma progression
por: Sini, Maria Cristina, et al.
Publicado: (2018)

Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
por: Palomba, Grazia, et al.
Publicado: (2016)

Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer
por: Fois, Sara S., et al.
Publicado: (2021)

Molecular analysis of appendiceal mucinous cystadenoma and rectal adenocarcinoma in a patient with urothelial carcinoma: a case report
por: Pulighe, Fabio, et al.
Publicado: (2013)

Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
por: Palomba, Grazia, et al.
Publicado: (2016)

BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas
por: Colombino, Maria, et al.
Publicado: (2019)

Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches
por: Palmieri, Giuseppe, et al.
Publicado: (2018)

Duration of Immunotherapy in Non-Small Cell Lung Cancer Survivors: A Lifelong Commitment?
por: Putzu, Carlo, et al.
Publicado: (2023)

Lung cancer epidemiology in North Sardinia, Italy
por: Paliogiannis, Panagiotis, et al.
Publicado: (2013)

Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study
por: Casula, Milena, et al.
Publicado: (2019)

Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients
por: Mariani, Stefano, et al.
Publicado: (2022)

Epidemiology of Thyroid Cancer in an Area of Epidemic Thyroid Goiter
por: Cossu, Antonio, et al.
Publicado: (2013)

Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective
por: Ombra, Maria Neve, et al.
Publicado: (2019)

Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era
por: Palmieri, Maria, et al.
Publicado: (2023)

The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something?
por: Ottaviano, Margaret, et al.
Publicado: (2021)

Inflammatory Indexes as Predictive Biomarkers of Postoperative Complications in Oncological Thoracic Surgery
por: Ginesu, Giorgio Carlo, et al.
Publicado: (2022)

Primary Dermal Melanoma in a Patient with a History of Multiple Malignancies: A Case Report with Molecular Characterization
por: Sini, Germana, et al.
Publicado: (2013)

Current Trends in Mucosal Melanomas: An Overview
por: Santeufemia, Davide Adriano, et al.
Publicado: (2023)

Vitamin D status and risk for malignant cutaneous melanoma: recent advances
por: Ombra, Maria N., et al.
Publicado: (2017)

Clinical Perspective and Translational Oncology of Liquid Biopsy
por: Fernández-Lázaro, Diego, et al.
Publicado: (2020)

Liquid biopsies in pediatric oncology: opportunities and obstacles
por: Sundby, R. Taylor, et al.
Publicado: (2022)

The coming of age of liquid biopsy in neuro-oncology
por: Berzero, Giulia, et al.
Publicado: (2023)

Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review)
por: Finotti, Alessia, et al.
Publicado: (2018)

Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia
por: Palomba, Grazia, et al.
Publicado: (2012)

Radiomics and liquid biopsy in oncology: the holons of systems medicine
por: Neri, Emanuele, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4reh0dku8jg8k4qopt1g5arn7c